CBD Life Sciences Inc. (CBDL) Announces New Manufacturing Deal With A Southwest-Based Company
CBD Life Sciences Inc. (CBDL) has announced a strategic manufacturing partnership with Jeannie in a Bottle, an Arizona-based CBD company. Under this agreement, CBDL will handle the production, packaging, and labeling of high-potency CBD products exclusively for Jeannie in a Bottle, which has a presence in over 100 gas stations and convenience stores across the United States.
The partnership leverages Jeannie in a Bottle's established retail network while utilizing CBDL's manufacturing capabilities. This collaboration is expected to generate consistent monthly reorders and strengthen CBDL's revenue pipeline through ongoing production contracts. The deal strategically positions CBDL to expand its national presence in the growing CBD wellness market through the convenience store and gas station retail channel.
CBD Life Sciences Inc. (CBDL) ha annunciato una partnership strategica di produzione con Jeannie in a Bottle, un'azienda di CBD con sede in Arizona. Secondo questo accordo, CBDL si occuperà della produzione, confezionamento ed etichettatura di prodotti CBD ad alta potenza esclusivamente per Jeannie in a Bottle, presente in oltre 100 stazioni di servizio e negozi di convenienza negli Stati Uniti.
La collaborazione sfrutta la rete di vendita al dettaglio consolidata di Jeannie in a Bottle, integrandola con le capacità produttive di CBDL. Questa alleanza si prevede genererà ordini mensili costanti e rafforzerà il flusso di entrate di CBDL attraverso contratti di produzione continuativi. L'accordo posiziona strategicamente CBDL per espandere la sua presenza a livello nazionale nel mercato in crescita del benessere a base di CBD, tramite il canale di vendita nei negozi di convenienza e stazioni di servizio.
CBD Life Sciences Inc. (CBDL) ha anunciado una alianza estratégica de fabricación con Jeannie in a Bottle, una empresa de CBD con sede en Arizona. Según este acuerdo, CBDL se encargará de la producción, el envasado y el etiquetado de productos de CBD de alta potencia exclusivamente para Jeannie in a Bottle, que cuenta con presencia en más de 100 estaciones de servicio y tiendas de conveniencia en Estados Unidos.
La asociación aprovecha la red minorista establecida de Jeannie in a Bottle, utilizando la capacidad de fabricación de CBDL. Se espera que esta colaboración genere pedidos mensuales constantes y fortalezca los ingresos de CBDL mediante contratos de producción continuos. El acuerdo posiciona estratégicamente a CBDL para expandir su presencia nacional en el creciente mercado de bienestar con CBD a través del canal minorista de tiendas de conveniencia y estaciones de servicio.
CBD Life Sciences Inc. (CBDL)는 애리조나에 기반을 둔 CBD 기업인 Jeannie in a Bottle과 전략적 제조 파트너십을 발표했습니다. 이 계약에 따라 CBDL은 Jeannie in a Bottle을 위해 고효능 CBD 제품의 생산, 포장 및 라벨링을 독점적으로 담당하며, Jeannie in a Bottle은 미국 전역의 100개 이상의 주유소 및 편의점에 입점해 있습니다.
이번 파트너십은 Jeannie in a Bottle의 확립된 소매망을 활용하고 CBDL의 제조 역량을 결합합니다. 이 협력은 지속적인 월별 재주문을 창출하고 지속적인 생산 계약을 통해 CBDL의 수익 파이프라인을 강화할 것으로 기대됩니다. 이번 계약은 CBDL이 편의점 및 주유소 소매 채널을 통해 성장하는 CBD 웰니스 시장에서 전국적 입지를 확장하는 데 전략적으로 기여합니다.
CBD Life Sciences Inc. (CBDL) a annoncé un partenariat stratégique de fabrication avec Jeannie in a Bottle, une entreprise de CBD basée en Arizona. Dans le cadre de cet accord, CBDL prendra en charge la production, l'emballage et l'étiquetage de produits CBD à haute concentration exclusivement pour Jeannie in a Bottle, qui est présente dans plus de 100 stations-service et magasins de proximité à travers les États-Unis.
Ce partenariat tire parti du réseau de distribution établi de Jeannie in a Bottle tout en utilisant les capacités de fabrication de CBDL. Cette collaboration devrait générer des réapprovisionnements mensuels réguliers et renforcer le flux de revenus de CBDL grâce à des contrats de production continus. Cet accord positionne stratégiquement CBDL pour étendre sa présence nationale sur le marché en pleine croissance du bien-être au CBD via le canal des magasins de proximité et des stations-service.
CBD Life Sciences Inc. (CBDL) hat eine strategische Produktionspartnerschaft mit Jeannie in a Bottle, einem in Arizona ansässigen CBD-Unternehmen, angekündigt. Im Rahmen dieser Vereinbarung übernimmt CBDL die Herstellung, Verpackung und Etikettierung von hochpotenten CBD-Produkten exklusiv für Jeannie in a Bottle, das in über 100 Tankstellen und Convenience Stores in den USA vertreten ist.
Die Partnerschaft nutzt das etablierte Einzelhandelsnetzwerk von Jeannie in a Bottle und kombiniert es mit den Fertigungskapazitäten von CBDL. Diese Zusammenarbeit soll konstante monatliche Nachbestellungen generieren und den Umsatzstrom von CBDL durch laufende Produktionsverträge stärken. Der Deal positioniert CBDL strategisch, um seine nationale Präsenz im wachsenden CBD-Wellnessmarkt über den Einzelhandelskanal von Convenience Stores und Tankstellen auszubauen.
- Access to 100+ retail locations nationwide through Jeannie in a Bottle's distribution network
- Secured recurring revenue stream through consistent monthly reorders
- Full control over production, packaging, and labeling processes
- Strategic entry into the growing convenience store and gas station retail channel
- None.
Strategic alliance positions CBDL for aggressive national growth through 100+ retail locations and new premium product lines
SCOTTSDALE, AZ / ACCESS Newswire / May 6, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), a leading innovator in the CBD health and wellness space, is proud to announce a new strategic manufacturing partnership with Jeannie in a Bottle, a fast-growing Arizona-based CBD company with a national retail footprint.
This powerful collaboration will see CBDL formulating and manufacturing top-tier CBD products for Jeannie in a Bottle - a company with proven market traction and shelf presence in over 100 gas stations and convenience stores across the United States. The deal expands CBDL's manufacturing portfolio while opening the door to high-volume, recurring product orders tied to Jeannie's established consumer base and retail distribution network. Under this agreement, CBDL will take full control of the production, packaging, and labeling of a specialized line of high-potency CBD products exclusively for Jeannie in a Bottle - a strategic move expected to significantly boost CBDL's nationwide revenue stream through consistent retail orders and brand expansion.
"This partnership is a win-win - not just for CBDL and Jeannie in a Bottle, but for shareholders and customers alike," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "We're stepping into a high-velocity retail environment with a proven brand, and bringing our own formulation and production strengths to the table. This is the kind of alignment that accelerates revenue, reputation, and results."
With CBDL managing product development, formulation, and manufacturing, Jeannie in a Bottle is positioned to scale its product offerings faster than ever - offering convenience store customers across the country consistent, compliant, and highly effective CBD wellness solutions.
Why This Deal Matters for CBDL Investors:
Built-In Distribution Power: Jeannie in a Bottle's existing footprint includes over 100 retail stores nationwide - giving CBDL immediate access to one of the most dynamic and accessible sales channels in the country.
Revenue Acceleration Potential: With consistent monthly reorders expected, the deal strengthens CBDL's revenue pipeline through ongoing production contracts and retail partnerships.
Brand Alignment & Synergy: Jeannie in a Bottle has a strong reputation for customer satisfaction, quality products, and effective formulations - values that align perfectly with CBDL's mission and vision.
Retail Momentum: The convenience store and gas station channel continues to see increased demand for functional wellness products, with CBD offerings leading the surge in consumer interest.
CBD Life Sciences Inc. continues to execute on its aggressive growth roadmap through smart, synergistic partnerships like this one - pairing established retail reach with premium product manufacturing to scale impact and revenue in tandem. With more partnerships and product innovations on the horizon, CBDL is positioning itself to be a national force in the CBD industry.

About CBD Life Sciences Inc. (CBDL):
CBD Life Sciences Inc. is a publicly traded company focused on the development and marketing of high-quality, science-backed CBD wellness products. Through strategic partnerships and proprietary manufacturing, CBDL continues to expand its footprint across health, retail, and nutraceutical markets nationwide. For more information, visit https://thecbdvault.com/
About Jeannie in a Bottle:
Based in Arizona, Jeannie in a Bottle is a rising CBD brand with a nationwide footprint, delivering high-quality CBD products through an expanding network of convenience stores and gas stations. Known for its effective formulations and loyal customer base, the company is committed to bringing accessible wellness solutions to everyday consumers.
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com
Stay Connected & Be the First to Try Our New Functional Mushroom Products!
Mushroom Madness Instagram: https://www.instagram.com/mushroom.madnessaz
Mushroom Madness Website: https://www.mushroommadness.shop
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contact Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720
SOURCE: CBD Life Sciences, Inc.
View the original press release on ACCESS Newswire